Advanced Medical Solutions
Advanced Medical Solutions, often referred to as AMS, is a leading provider of innovative medical technologies headquartered in Great Britain. Established in 1992, the company has made significant strides in the healthcare sector, particularly in wound care and advanced surgical solutions. With a strong presence in Europe and expanding operations in North America, AMS is renowned for its commitment to enhancing patient outcomes through cutting-edge products. The company’s core offerings include advanced wound care dressings, surgical adhesives, and innovative biomaterials, all designed to promote healing and improve surgical efficiency. What sets AMS apart is its focus on research and development, ensuring that its products are at the forefront of medical advancements. Recognised for its quality and reliability, Advanced Medical Solutions continues to solidify its position as a trusted partner in the global healthcare market.
DitchCarbon Score
How does Advanced Medical Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Advanced Medical Solutions's score of 46 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Advanced Medical Solutions's reported carbon emissions
In 2024, Advanced Medical Solutions (AMS), headquartered in Great Britain, reported total carbon emissions of approximately 1,689,040 kg CO2e. This figure includes 2,409,000 kg CO2e from Scope 1 emissions, primarily from direct operations, and 835,190 kg CO2e from Scope 2 emissions, mainly from purchased electricity. The previous year, 2023, AMS recorded total emissions of about 1,587,120 kg CO2e, with Scope 1 emissions at 863,670 kg CO2e and Scope 2 emissions at 708,660 kg CO2e. AMS has set ambitious climate commitments, aiming for a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030, using a 2021 baseline. Furthermore, the company is committed to achieving Net Zero emissions across all scopes (1, 2, and 3) by 2045. This long-term goal reflects AMS's dedication to sustainability and aligns with industry standards for climate action. The company has initiated its 'Pathway to Net Zero' project, which began in 2022, to further integrate its Environmental, Social, and Governance (ESG) framework. AMS's emissions data and reduction targets are sourced from its parent organization, Advanced Medical Solutions Group plc, ensuring a comprehensive approach to its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 565,517 | 0,000,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 1,310,640 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 22,838 | 000,000 | 000,000 | 000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Advanced Medical Solutions is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
